Cargando…

Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles

BACKGROUND: A promising approach to optimize the disposition of daunorubicin-loaded magnetic nanoparticles (DNR-MNPs) was developed to minimize serious side effects of systematic chemotherapy for cancer. METHODS: The physical properties of DNR-MNPs were investigated and their effect on leukemia cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jun, Chen, Baoan, Chen, Jian, Cai, Xiaohui, Xia, Guohua, Liu, Ran, Chen, Pingsheng, Zhang, Yu, Wang, Xuemei
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061434/ https://www.ncbi.nlm.nih.gov/pubmed/21445276 http://dx.doi.org/10.2147/IJN.S16165

Ejemplares similares

A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin
por: Cheng, Jian, et al.
Publicado: (2011)

Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin
por: Wang, Jun, et al.
Publicado: (2011)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
por: Bao, Wen, et al.
Publicado: (2019)

Magnetic nanoparticle of Fe(3)O(4) and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells
por: Chen, Baoan, et al.
Publicado: (2009)

Reversal of multidrug resistance by magnetic Fe(3)O(4) nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice
por: Chen, Baoan, et al.
Publicado: (2009)

Daunorubicin-TiO(2) nanocomposites as a “smart” pH-responsive drug delivery system
por: Zhang, Haijun, et al.
Publicado: (2012)

The changes of T lymphocytes and cytokines in ICR mice fed with Fe(3)O(4) magnetic nanoparticles
por: Wang, Jun, et al.
Publicado: (2011)

Reversal of multidrug resistance by cisplatin-loaded magnetic Fe(3)O(4) nanoparticles in A549/DDP lung cancer cells in vitro and in vivo
por: Li, Ke, et al.
Publicado: (2013)

Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells
por: Wang, Lei, et al.
Publicado: (2012)

PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway
por: Bao, Wen, et al.
Publicado: (2015)

Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo
por: Chen, Bao-an, et al.
Publicado: (2009)

Multifunctional magnetic Fe(3)O(4) nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
por: Ren, Yanyan, et al.
Publicado: (2012)

Effect of magnetic Fe(3)O(4) nanoparticles with 2-methoxyestradiol on the cell-cycle progression and apoptosis of myelodysplastic syndrome cells
por: Xia, Guohua, et al.
Publicado: (2011)

Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells
por: Zhou, Ya-Lan, et al.
Publicado: (2018)

Effect of magnetic nanoparticles of Fe(3)O(4) and wogonin on the reversal of multidrug resistance in K562/A02 cell line
por: Cheng, Jian, et al.
Publicado: (2012)

Biocompatibility of Fe(3)O(4)/DNR magnetic nanoparticles in the treatment of hematologic malignancies
por: Wu, Weiwei, et al.
Publicado: (2010)

Magnetic Fe(3)O(4) nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
por: Jing, Hongmei, et al.
Publicado: (2010)

Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe(3)O(4) combined with cyclosporin A in murine models
por: Cheng, Jian, et al.
Publicado: (2011)

Reversal of multidrug resistance by magnetic Fe(3)O(4) nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells
por: Chen, Bao-an, et al.
Publicado: (2010)

Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle‐Based Anticancer Drug
por: Mai, Ngoc Xuan Dat, et al.
Publicado: (2020)

Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice
por: Wang, Jun, et al.
Publicado: (2010)

Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
por: Schuster, Sabine, et al.
Publicado: (2018)

Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells
por: Chen, Baoan, et al.
Publicado: (2009)

Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
por: Liu, Ran, et al.
Publicado: (2015)

Reversal in multidrug resistance by magnetic nanoparticle of Fe(3)O(4) loaded with adriamycin and tetrandrine in K562/A02 leukemic cells
por: Chen, Baoan, et al.
Publicado: (2008)

Effect of interaction of magnetic nanoparticles of Fe(3)O(4) and artesunate on apoptosis of K562 cells
por: Wang, Ying, et al.
Publicado: (2011)

Effect of Fe(3)O(4)-magnetic nanoparticles on acute exercise enhanced KCNQ(1) expression in mouse cardiac muscle
por: Liu, Lijie, et al.
Publicado: (2010)

Enhancing the Therapeutic Efficacy of Daunorubicin and Mitoxantrone with Bavachinin, Candidone, and Tephrosin
por: Darzi, Sina, et al.
Publicado: (2019)

Adipocyte metabolism of the chemotherapy daunorubicin
por: Mittelman, Steven D., et al.
Publicado: (2018)

Synthesis and Cytotoxic Evaluation of Arimetamycin A and Its Daunorubicin and Doxorubicin Hybrids
por: Huseman, Eric D., et al.
Publicado: (2021)

Daunorubicin resensitizes Gram-negative superbugs to the last-line antibiotics and prevents the transmission of antibiotic resistance
por: Cai, Jinju, et al.
Publicado: (2023)

Gambogic acid-loaded magnetic Fe(3)O(4) nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1
por: Wang, Cailian, et al.
Publicado: (2012)

Green Synthesis of Gold Nanoparticles Using Carrageenan Oligosaccharide and Their In Vitro Antitumor Activity
por: Chen, Xiangyan, et al.
Publicado: (2018)

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987)

Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma
por: Chen, Bin, et al.
Publicado: (2015)

Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
por: Zhu, Yuanyuan, et al.
Publicado: (2023)

Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment
por: Guo, Dan, et al.
Publicado: (2020)

Liposomal daunorubicin as treatment for Kaposi’s sarcoma
por: Petre, Christin E, et al.
Publicado: (2007)

Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

Fluorescence spectra of cardiac myosin and in vivo experiment: studies on daunorubicin-induced cardiotoxicity
por: Liu, Yang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_npd92cohqvd513qnrbj90pu4lp